1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.06.23 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 01.06.2023 | 1.144 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 01.06.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 01.06.2023ISIN NameFR00140077X1 NEOVACS... ► Artikel lesen | |
| 24.05.23 | Nasdaq Stockholm AB: Delisting of ISR Immune System Regulation Holding AB (publ) from Nasdaq First North Growth Market (287/23) | 603 | GlobeNewswire | Today, May 24, 2023, the Disciplinary Committee of Nasdaq Stockholm AB decided
that the shares in ISR Immune System Regulation Holding AB (publ) should be
delisted no later than June 22, 2023.
Nasdaq... ► Artikel lesen | |
| 24.05.23 | Decision by the Disciplinary Committee regarding ISR Immune System Regulation Holding AB (publ) | 499 | GlobeNewswire | Stockholm, May 24, 2023- The Disciplinary Committee of Nasdaq Stockholm AB (the
"Exchange") has found that ISR Immune System Regulation Holding AB (publ)
("ISR" or the "Company") has breached the Nasdaq... ► Artikel lesen |
3 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS | 19,805 | -1,17 % | Intellia Therapeutics, Inc. - 8-K, Current Report | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 1,339 | -2,69 % | Pacific Biosciences of California, Inc.: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance | Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million
Q1 2024 Earnings Conference Call Scheduled for May 9, 2024
MENLO PARK, Calif., April 16, 2024 /PRNewswire/... ► Artikel lesen | |
| CENTOGENE | 0,446 | +3,24 % | Centogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notice | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) ("Centogene", "we", or the "Company"), the essential life science partner for data-driven... ► Artikel lesen | |
| ATAI LIFE SCIENCES | 1,925 | +7,00 % | atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights | Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003... ► Artikel lesen | |
| BIOMERIEUX | 100,50 | +1,82 % | Biomerieux shares eye best day in 25 mths after better-than-expected Q1 | ||
| CYCLACEL | 1,810 | 0,00 % | Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | - On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 - - Expect to Report Final Data from Fadraciclib 065-101 Dose Escalation - - Oral Plogosertib Preclinical Data Support Precision... ► Artikel lesen | |
| SYROS PHARMACEUTICALS | 4,500 | +0,90 % | Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies... ► Artikel lesen | |
| GENUS | 19,900 | -0,50 % | Dividendenbekanntmachungen (29.02.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,14 USD 0,1291 EUR AGNICO EAGLE MINES LIMITED CA0084741085 0,4 USD 0,369 EUR ALLIANCE... ► Artikel lesen | |
| ATRECA | 0,155 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.03.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 28.03.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.03.2024ISIN NameGB00BZ2JBG28 REACT... ► Artikel lesen | |
| ANAPTYSBIO | 18,300 | -1,08 % | Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week | ||
| ABIONYX PHARMA | 1,026 | 0,00 % | ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital | Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX)
Market:... ► Artikel lesen | |
| MEIRAGTX | 4,620 | -4,15 % | MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference | ||
| METABOLIC EXPLORER | 0,189 | 0,00 % | XFRA 7ME: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| AKESO | 5,250 | 0,00 % | Akeso, Inc.: Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR | SAN DIEGO, April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined... ► Artikel lesen |
Das Unternehmen ISR IMMUNE SYSTEM REGULATION HOLDING AB kann der Branche Biotechnologie zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
